EHang Holdings Limited (NASDAQ:EH) ("EHang" or the "Company"), the world's leading autonomous aerial vehicle ("AAV") technology platform company, today announced that its long-range
As required by Rule 2.12 of the Takeover Rules, Sanofi S.A. ("Sanofi") confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash.
There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming.